Skip to content

Advances in Dual Diagnosis

ISSN 1757-0972

2 papers in the library · 24 citations · publishing 2014-2025

Papers

Sort Most recent Most cited

Using mindfulness-based cognitive therapy to reduce anxiety symptoms among individuals diagnosed with substance use disorder

Advances in Dual Diagnosis March 20, 2025 Mohannad A. Aldiqs, Ayman M. Hamdan-Mansour, Afaf Nowwara et al.

This study aims to examine the effectiveness of a brief six-session version of the mindfulness-based cognitive intervention derived from the positive psychology approach to decrease the symptoms of anxiety among individuals diagnosed with substance use disorders (SUDs). An experimental research design with pre- and post-tests and a one-month follow-up were used. The study sample comprised 34...

“Noids” in a nutshell: everything you (don’t) want to know about synthetic cannabimimetics

Advances in Dual Diagnosis August 12, 2014 Duccio Papanti, Laura Orsolini, Giulia Francesconi et al. 24 citations

Purpose – “Spice” products are synthetic cannabimimetics (SC; also called “synthetic cannabinoids”)-based designer drugs used as a legal alternative to cannabis for their very strong tetrahydrocannabinol (THC)-like effects. The purpose of this paper is to provide an analysis of more recent clinical and pharmacology/toxicology findings relating to SC and describe how they could impact on health,...

DOI: 10.1108/add-02-2014-0006 (opens in new tab) Cannabis Anxiety Synthetic cannabinoids Cannabinoid receptor +3